Atlas Trials

Fasting Study of Controlled-Release Oxycodone Hydrochloride 40 mg Tablets and OxyContin® 40 mg Tablets

Clinical trial NCT00853892 · COMPLETED

Trial details

NCT number
NCT00853892
Sponsor
Mallinckrodt
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2005-04-01
Primary completion
2005-04-01
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.